NIFTY 50 23415.15 ▲ (0.3%)
NIFTY NEXT 50 65001.65 ▼ (0.16%)
NIFTY 100 24101.2 ▲ (0.22%)
NIFTY MIDCAP 100 55118.45 ▲ (0.02%)
NIFTY SMALLCAP 100 17936.45 ▲ (0.4%)
NIFTY SMALLCAP 250 16918.6 ▲ (0.46%)
NIFTY MIDCAP SELECT 12325.1 ▼ (0.25%)
NIFTY TOTAL MARKET 12335.95 ▲ (0.25%)
NIFTY BANK 49318.85 ▼ (0.06%)
SENSEX 77176.46 ▲ (0.13%)
BSE BANKEX 55964.97 ▼ (0.13%)

Medinova Diagnostic Services Ltd.’s Quarterly Result and Earnings Report for Q4(Mar 2024) : Sales decreased by 9.38 % in YoY and increased by 4.36 % in QoQ

May 8, 2024May 8, 2024| adminadmin| 0 Comments| 1:00 pm
Image is loading
Categories:

Share the post "Medinova Diagnostic Services Ltd.’s Quarterly Result and Earnings Report for Q4(Mar 2024) : Sales decreased by 9.38 % in YoY and increased by 4.36 % in QoQ"

  • Facebook
  • LinkedIn
  • X
  • Tumblr
  • WhatsApp
  • TelegramTelegram
  • Email

Highlights

  • Sales over the Year and quarter: The company’s sales declined by -9.38 % over the year, substantial increase in net sales/revenue by 4.36 %.
  • Income over the Year and quarter: There has been decline in other income over the past year which is -18.75 %, Marginal increase in other income during this quarter, up by 333.33%.
  • Profit over the Year and quarter: Challenges in sustaining profitability for Medinova Diagnostic Services Ltd.. Profit dropped by -22.51 % Year to Year, Medinova Diagnostic Services Ltd.’s profitability increased by 48.64 % in this quarter.
  • EPS over the Year and quarter: EPS declined by -23.08 % Year to Year. EPS increased by 50 % in previous quarter. Positive impact on shareholders.

The comprehensive analytics outlining the performance and outlook of Medinova Diagnostic Services Ltd.”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 2.75 Cr Rs. 2.388 Cr Rs. 2.492 Cr + 4.36 % -9.38 %
Expenses Rs. 1.83 Cr Rs. 1.79 Cr Rs. 1.75 Cr -2.23 % -4.37 %
Operating Profit Rs. 0.92 Cr Rs. 0.6 Cr Rs. 0.74 Cr + 23.33 % -19.57 %
OPM % 33.45 % 25.13 % 29.7 % + 4.57 % -3.75 %
Other Income Rs. 0.16 Cr Rs. 0.03 Cr Rs. 0.13 Cr + 333.33 % -18.75 %
Interest Rs. 0.14 Cr Rs. 0.15 Cr Rs. 0.14 Cr -6.67 % + 0 %
Depreciation Rs. 0.04 Cr Rs. 0.03 Cr Rs. 0.03 Cr + 0 % -25 %
Profit before tax Rs. 0.9 Cr Rs. 0.45 Cr Rs. 0.7 Cr + 55.56 % -22.22 %
Tax % 14.4 % 10.64 % 14.79 % + 4.15 % + 0.39 %
Net Profit Rs. 0.77 Cr Rs. 0.4 Cr Rs. 0.6 Cr + 50 % -22.08 %
EPS in Rs Rs. 0.78 Rs. 0.4 Rs. 0.6 + 50 % -23.08 %


Today, we’re looking at Medinova Diagnostic Services Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -9.38 %. However, it did see a marginal increase of 4.36 % from the previous quarter. Expenses decreased slightly by -2.23 % quarter-on-quarter, aligning with the annual decline of -4.37 %. Operating profit, while down -19.57 % compared to last year, faced a quarter-on-quarter increase of 23.33 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -3.75 %, but an expansion of 4.57 % sequentially. Other income rose by 333.33 % compared to the last quarter, despite an annual decline of -18.75 %. Interest expenses dropped significantly by -6.67 % from the previous quarter, yet the year-over-year increase remains at a moderate 0 %. Depreciation costs climbed by 0 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -25 %. Profit before tax declined annually by -22.22 % but saw an increase from the preceding quarter by 55.56 %.
Tax expenses as a percentage of profits increased slightly by 0.39 % compared to last year, with a more notable quarter-on-quarter increase of 4.15 %. Net profit fell by -22.08 % year-on-year but experienced a 50 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -23.08 % but a quarterly rise of 50 %. In summary, Medinova Diagnostic Services Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 2.75 Cr Rs. 2.388 Cr Rs. 2.492 Cr + 4.36 % -9.38 %
Expenses Rs. 1.83 Cr Rs. 1.79 Cr Rs. 1.75 Cr -2.23 % -4.37 %
Operating Profit Rs. 0.92 Cr Rs. 0.6 Cr Rs. 0.74 Cr + 23.33 % -19.57 %
Net Profit Rs. 0.77 Cr Rs. 0.4 Cr Rs. 0.6 Cr + 50 % -22.08 %
EPS in Rs Rs. 0.78 Rs. 0.4 Rs. 0.6 + 50 % -23.08 %


In reviewing Medinova Diagnostic Services Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -9.38 % year-on-year, however, there was a minor increase of 4.36 % from the previous quarter. Expenses decreased by -4.37 % compared to the previous year, with a decrease of -2.23 % quarter-on-quarter. Operating Profit dropped by -19.57 % annually, and saw a 23.33 % increase from the last quarter.
Net Profit showed yearly decrease of -22.08 %, and experienced a 50 % increase from the previous quarter. Earnings Per Share (EPS) fell by -23.08 % annually, however rose by 50 % compared to the last quarter. In essence, while Medinova Diagnostic Services Ltd. faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”Medinova Diagnostic Services Ltd.”]

Related Post